MarkMD partner:

The department of Medical Genetics and the Department for Neurodegenerative Disorders of the Hertie Institute for Clinical Brain Research form a Europe-wide unique environment for research on neurodegenerative diseases that integrates excellence in clinical, neuroimaging, genetic, molecular, pathogenesis-focussed, and preclinical research. Participation in EU funded collaborative projects includes:

• European integrated project on Spinocerebellar Ataxias (EUROSCA), Jan 2004 – Dec 2008, coordinator,
• European project on the characterisation of transgenic rat models for neurodegenerative and psychiatric diseases: Automated home cage analyses, live imaging and treatment. (RATstream), Jan 2007 – Dec 2009, coordinator,

Hertie Institute for Clinical Brain Research

Department of Medical Genetics

deCODE genetics is widely recognised as a centre of excellence in genetic research and participates in a number of international collaborative projects with diverse dissemination and exchange schemes. The projects include:

• EU: Genomics, mechanisms and treatment of addiction (Genaddict), Jan 05 -Dec 09, partner,

• EU: Inherited risk of breast and prostate cancer (Polygene), Dec 05 - Sept 09, coordinator,

• EU: A large scale GWA study of Schizophrenia (SGENE), Nov 06-Oct 09, coordinator,

• NIDA: Genes contributing to nicotine dependence in humans, Aug 05-April 09, PI,

• NIMH: Isolation of autism susceptibility genes, Aug 06 – 31 May 11, PI,

• NIDA: Genes contributing to opioid use in humans, 5 years, starting in 2007, PI,

deCode genetics building

Implementation of the partnership in MarkMD